Daiichi Sankyo traded at 2,799.50 this Friday July 24th, increasing 44.50 or 1.62 percent since the previous trading session. Looking back, over the last four weeks, Daiichi Sankyo gained 9.08 percent. Over the last 12 months, its price fell by 22.88 percent. Looking ahead, we forecast Daiichi Sankyo to be priced at 2,670.16 by the end of this quarter and at 2,316.91 in one year, according to Trading Economics global macro models projections and analysts expectations.
Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.